Fine-Tuned and Cell-Cycle-Restricted Expression of Fusogenic Protein Syncytin-2 Maintains Functional Placental Syncytia.

Cell Reports
Xiaoyin LuH Wang

Abstract

Many types of multinucleated cells (syncytia) generated by cell-cell fusion are post-mitotic, but it remains unclear how this state is maintained and why. Here, we utilized the fluorescent ubiquitination-based cell-cycle indicator (Fucci) reporter system to show that human placental trophoblast cells were all in the G0 phase before they fuse. Expression of the fusogenic protein (fusogen) Syncytin-2 was confined to G0 cells. Overexpression of Syncytin-2 in cycling cells overrode the cell-cycle restriction and enabled fusion of cells in the S/G2/M phases but resulted in the unstable syncytia retaining mitotic features. The Syncytin-2-induced syncytia were functionally compromised with respect to pathogen defense and hormone secretion. We found that, during trophoblast fusion, the cell-cycle inhibitor p21 interacted with the GCM1 transcription factor, and this complex bound to the promoter of Syncytin-2 and promoted its transcription. These findings demonstrate that G0-restricted Syncytin-2 expression is a prerequisite for development of functional post-mitotic syncytia.

Citations

Jan 8, 2019·Reviews in Medical Virology·Mengwen ZhangShu Zheng
Sep 10, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Caroline ToudicBenoit Barbeau
Oct 24, 2019·Cellular and Molecular Life Sciences : CMLS·Bide ChenTizhong Shan
Jun 6, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hua ZhuPeter C K Leung
Jul 1, 2020·Nature Reviews. Endocrinology·John D AplinMelissa Westwood
Mar 28, 2018·Proceedings of the National Academy of Sciences of the United States of America·Pengpeng BiEric N Olson
Aug 14, 2019·Journal of Molecular Cell Biology·Rui WangHongmei Wang
Dec 22, 2019·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Désirée ForstnerMartin Gauster
Dec 31, 2020·Proceedings of the National Academy of Sciences of the United States of America·Rui WangLei Li
Jun 1, 2021·Frontiers in Cell and Developmental Biology·Clara ApicellaFrancisco Miralles
Jun 15, 2021·Human Reproduction Update·John D Aplin, Carolyn J P Jones
Jul 3, 2021·Frontiers in Cell and Developmental Biology·Adam JaremekStephen J Renaud
Jul 25, 2021·Nature Communications·Daniel FelicianoJennifer Lippincott-Schwartz
Oct 5, 2021·Journal of Molecular Biology·Maaran Michael RajahOlivier Schwartz

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.